Sort by
Refine Your Search
-
Category
-
Program
-
Employer
- IDIVAL
- University of A Coruña
- Basque Center for Applied Mathematics
- CNAG
- FUNDACION DE INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE
- Fundació Centre de Recerca en Agrotecnologia-AGROTECNIO
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Fundación Investigación Biomédica del Hospital de la Princesa
- IBIMA Plataforma BIONAND
- ICMAB
- Theory of Nanophotonics group
- UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA
- Universidad Autónoma de Madrid
- Universitat de les Illes Balears
- University of Girona (UdG) - Institute of Computational Chemistry and Catalysis (IQCC)
- 5 more »
- « less
-
Field
-
multimodal algorithm of epigenetic blood predictors of the clinical benefit of SBRT in immunotherapy-resistant tumors Research Line: IBIMA-BE-17 CLINICAL, MOLECULAR, AND TECHNOLOGICAL RESEARCH IN RADIATION
-
project and support the organization and management of the laboratory. Specifically: • Use of cell and molecular biology techniques: -Maintenance and handling of primary cultures and cell lines. Preparation
-
. They will carry out physico-chemical stability tests and controlled-release studies in biological and simulated media, applying techniques from biochemistry, cell biology and molecular biology, including
-
minimum score of 40 points in the selection criteria detailed in Blocks 1 and 2. The minimum score required to be included on the waiting list will be 60 points. Where to apply Website https://sede.udc.gal
-
on endocrine and neuroendocrine tumours, integrating preclinical models, molecular profiling and translational approaches to identify novel therapeutic vulnerabilities and biomarkers associated with treatment
-
preservation of the DNA biobank, genotyping of polymorphisms and copy number variation, Sanger sequencing, and development of new genotyping and molecular genetics technologies. • Analysis of drugs and
-
experts can bridge the gaps across genetics, molecular biology, bioinformatics, biostatistics, clinical research, cancer epidemiology and aetiology, and data science to advance breast cancer research and